Prasterone phosphocholine - Astex Pharmaceuticals
Alternative Names: dehydroepiandrosterone phosphocholine; DHEA phosphocholineLatest Information Update: 25 Jul 2018
At a glance
- Originator SuperGen
- Class Antihyperglycaemics
- Mechanism of Action Dehydroepiandrosterone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 12 Jul 2001 Preclinical development for Type-2 diabetes mellitus in USA (Unknown route)